Can the galenic form of GnRH agonist used during long IVF protocol vary the pregnancy rate?;Le type d'analogue de la GnRH utilise au cours des protocoles longs en FIV peut-il influencer les taux de grossesse?

Contraception Fertilite Sexualite

Volumn 24, Issue 10, 1996, Pages 762-766

  Librati, C ^a   Hocke, C ^a   Filet, J P ^a   Papaxanthos, A ^a   Mene, D ^a   Dulucq, M C ^a   Leng, J J ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

FIV; GnRH agonist; long IVF protocole; luteal defect; ovarian stimulation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; LEUPRORELIN; PROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL REGULATION; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; LUTEOLYTIC AGENTS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TIME FACTORS; TRIPTORELIN;

EID: 0029906785     PISSN: 11578181     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)